L.E.K.’s Take on China Medtech: Optimistic Macro View, Short-Term Hit Hard Stephen Sunderland Read more
Related Practice MedTech Despite the COVID-19 lockdown, Stephen Sunderland foresees limited disruption 07102020100744
Smart Chart Life Sciences & Pharma The Race to Lead in Life Sciences Innovation: Lessons from Global Benchmarks December 30, 2025
Video / Webinar Life Sciences & Pharma Pharma Growth in China: Key Partnerships and Global Opportunities November 14, 2025
Special Report Contract/Pharma Services Advancing Innovation and Global Reach: The Next Chapter in China’s Clinical Trial… November 12, 2025
Executive Insights Life Sciences & Pharma Unleashing Growth: How Innovation Is Reshaping Animal Health September 12, 2025
Executive Insights Life Sciences & Pharma Advanced In Vitro Models: Opportunities and Challenges for US Drug Development May 7, 2025
